Company / Cash per Share
ENDONOVO THERAPEUTICS, INC. Cash per Share History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.00
FY2021
5-year range
$0.00 / $0.04
FY2017-FY2021
Trend
-69.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.04 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2021 with a 5-year CAGR of +45.9%.
Declined from $0.04 to $0.00 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +43.1%
- 5-Year CAGR
- +45.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, cash per share decreased 69.0% year-over-year.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -76.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | $0.00 | -69.0% |
| FY2020 | $0.01 | -74.3% |
| FY2019 | $0.04 | +3563.9% |
| FY2018 | $0.00 | +125.8% |
| FY2016 | $0.00 | +4.0% |
| FY2015 | $0.00 | -57.1% |
| FY2014 | $0.00 | - |
| FY2011 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 29, 2026